Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

Phillip H Kuo, Emanuel Kanal, Ali K. Abu-Alfa, Shawn E. Cowper

Research output: Contribution to journalArticle

441 Citations (Scopus)

Abstract

While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

Original languageEnglish (US)
Pages (from-to)647-649
Number of pages3
JournalRadiology
Volume242
Issue number3
DOIs
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Nephrogenic Fibrosing Dermopathy
Gadolinium
Contrast Media
Kidney

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. / Kuo, Phillip H; Kanal, Emanuel; Abu-Alfa, Ali K.; Cowper, Shawn E.

In: Radiology, Vol. 242, No. 3, 03.2007, p. 647-649.

Research output: Contribution to journalArticle

Kuo, Phillip H ; Kanal, Emanuel ; Abu-Alfa, Ali K. ; Cowper, Shawn E. / Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. In: Radiology. 2007 ; Vol. 242, No. 3. pp. 647-649.
@article{02cad516a5734b399e61a5642fdc2f73,
title = "Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis",
abstract = "While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.",
author = "Kuo, {Phillip H} and Emanuel Kanal and Abu-Alfa, {Ali K.} and Cowper, {Shawn E.}",
year = "2007",
month = "3",
doi = "10.1148/radiol.2423061640",
language = "English (US)",
volume = "242",
pages = "647--649",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

AU - Kuo, Phillip H

AU - Kanal, Emanuel

AU - Abu-Alfa, Ali K.

AU - Cowper, Shawn E.

PY - 2007/3

Y1 - 2007/3

N2 - While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

AB - While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

UR - http://www.scopus.com/inward/record.url?scp=33847239121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847239121&partnerID=8YFLogxK

U2 - 10.1148/radiol.2423061640

DO - 10.1148/radiol.2423061640

M3 - Article

C2 - 17213364

AN - SCOPUS:33847239121

VL - 242

SP - 647

EP - 649

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -